12 September 2022 - Today, at the 72nd session of the WHO Regional Committee for Europe, 53 countries signed a statement committing to identify solutions to improve access to effective, novel and high-priced medicines in the Region through a multistakeholder platform.
Member States of the WHO European Region have voiced concern over the escalating prices and budgetary impact of novel medicines, which have restricted patient access.